Filter
201
Filtered Results: 201
Text search:
National
Pharmacovigilance
and
Medicines
Information
Center
Featured
Recommendations
25
New Publications
57
Language
Document type
No document type
107
Guidelines
31
Studies & Reports
30
Manuals
14
Strategic & Response Plan
10
Training Material
4
Situation Updates
3
Fact sheets
2
Countries / Regions
Nigeria
10
Namibia
10
Kenya
9
Rwanda
9
Ethiopia
9
India
9
Ghana
7
South Africa
6
Nepal
5
Cambodia
5
Liberia
5
Philippines
4
Latin America and the Carribbean
4
Tanzania
4
Eastern Europe
4
Zambia
4
Mozambique
3
Western and Central Europe
3
Uganda
3
Russia
3
Ukraine
2
Sierra Leone
2
Malawi
2
Asia
2
West and Central Africa
2
South–East Asia Region
2
Bangladesh
2
Botswana
2
Indonesia
2
Pakistan
2
Thailand
1
Lesotho
1
Gambia
1
Cameroon
1
Laos
1
Senegal
1
Afghanistan
1
Zimbabwe
1
Global
1
Africa
1
Haiti
1
Jordan
1
Middle East and North Africa
1
Western Pacific Region
1
East and Southern Africa
1
Argentina
1
Vietnam
1
Sri Lanka
1
Georgia
1
Libya
1
Bhutan
1
Myanmar / Burma
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
108
Clinical Guidelines
19
Public Health
7
Capacity Building
4
Key Resources
3
Women & Child Health
2
Pharmacy & Technologies
1
Toolboxes
TB
21
Pharmacy
21
AMR
20
COVID-19
15
HIV
12
Malaria
7
NTDs
6
Planetary Health
3
Refugee
2
Ebola & Marburg
2
Rapid Response
1
Caregiver
1
NCDs
1
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
Tuberculosis continues to represent a severe public health problem in the Region of the Americas, even more so in the case of indigenous peoples, whose TB incidence is much higher than that of the general population. To achieve tuberculosis control in these communities, it is necessary to respond t...
Nepal has only recently started its journey on the path to an integrated response to the challenge of antimicrobial resistance (AMR). Despite this, it is notable that the Nepal Health Sector Strategy Plan (HSSP)-2 mentions growing antibiotic resistanceas a public health challenge.
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
Advances have been made through expanded interventions delivered through five public health approaches: innovative and intensified disease management; preventive chemotherapy; vector ecology and management; veterinary public health services; and the provision of safe water, sanitation and hygiene. I...
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infec...
This fourth WHO report on neglected tropical diseases (NTDs) reviews the progress made towards achieving the Roadmap targets for 2020, noting the remaining challenges, then looks beyond 2020 to evaluate the changing global health and development landscape, considering the implications of integrating...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
Against this background of nearly 20 years of experience of research, development and
improvement in patient safety, the role of incident and adverse event reporting, as well as the
benefits that derive from it, is still a work in progress.This document has two main purposes:
• to provide an up...
Supplement Article
www.jaids.com J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
This document provides a decision-making framework for implementation of mass treatment interventions, active case-finding campaigns and population-based surveys for neglected tropical diseases in the context of the COVID-19 pandemic. A two-step approach is proposed: a risk–benefit assessment, to ...
